Baudax Bio Correlations
| BXRXDelisted Stock | USD 0.76 0.06 7.32% |
The current 90-days correlation between Baudax Bio and Altamira Therapeutics is 0.1 (i.e., Average diversification). The correlation of Baudax Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Baudax Bio Correlation With Market
Significant diversification
The correlation between Baudax Bio and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Baudax Bio and DJI in the same portfolio, assuming nothing else is changed.
Baudax |
Moving together with Baudax Stock
| 0.68 | DPSTF | Deutsche Post AG | PairCorr |
| 0.68 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
| 0.61 | KO | Coca Cola Earnings Call This Week | PairCorr |
Moving against Baudax Stock
| 0.71 | DIS | Walt Disney Earnings Call This Week | PairCorr |
| 0.61 | V | Visa Class A | PairCorr |
| 0.55 | AMZN | Amazon Inc Earnings Call This Week | PairCorr |
| 0.54 | WMT | Walmart Aggressive Push | PairCorr |
| 0.54 | AXP | American Express | PairCorr |
| 0.43 | IBM | International Business Tech Boost | PairCorr |
| 0.4 | JPM | JPMorgan Chase | PairCorr |
| 0.36 | T | ATT Inc Earnings Call This Week | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Baudax Stock performing well and Baudax Bio Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Baudax Bio's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| VRAX | 6.32 | (0.36) | 0.00 | (0.13) | 0.00 | 19.90 | 59.66 | |||
| YS | 4.91 | (0.58) | 0.00 | (3.81) | 0.00 | 10.29 | 36.81 | |||
| NEXI | 4.85 | (0.37) | 0.00 | (0.45) | 0.00 | 5.90 | 94.30 | |||
| CYTO | 4.99 | (2.16) | 0.00 | (5.01) | 0.00 | 7.32 | 38.46 | |||
| PALI | 5.76 | (0.94) | 0.00 | 28.73 | 0.00 | 12.73 | 93.57 | |||
| CFRX | 5.26 | (0.24) | 0.00 | 0.72 | 0.00 | 12.23 | 55.69 | |||
| ALLR | 4.39 | (0.28) | 0.00 | (0.79) | 0.00 | 6.93 | 47.01 | |||
| CNSP | 4.18 | (0.23) | 0.00 | 0.34 | 0.00 | 10.00 | 24.15 | |||
| WINT | 4.34 | (2.67) | 0.00 | (8.02) | 0.00 | 8.93 | 32.37 | |||
| QNRX | 5.66 | (0.99) | 0.00 | 3.88 | 0.00 | 14.29 | 58.63 |
View Baudax Bio Related Equities
| Risk & Return | Correlation |
Baudax Bio Corporate Management
| Natalie McAndrew | Consultant Officer | Profile | |
| Jillian Dilmore | Corp Controller | Profile | |
| Diane Myers | VP Quality | Profile | |
| Mike Choi | Vice Analysis | Profile |
Still Interested in Baudax Bio?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.